Nicholas J. Singer - 02 Dec 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Dec 2022, 17:52:09 UTC
Prior SEC filing
03 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nicholas J. Singer

Key filing fact

Nicholas J. Singer filed Form 4 for Eterna Therapeutics Inc. (ERNA) on 06 Dec 2022.

Key facts

  • This page summarizes Nicholas J. Singer's Form 4 filing for Eterna Therapeutics Inc. (ERNA).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 06 Dec 2022, 17:52.

Change

  • Previous filing in this sequence was filed on 03 Aug 2022.
  • Current net transaction value: +$1,000,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ERNA transaction

Common Stock

Purchase

Transaction value
$232,296
Shares
+70,822
Change %
+139%
Price
$3.28
Shares after
121,822
Date
02 Dec 2022
Ownership
By Purchase Capital LLC
Footnotes
F1
ERNA transaction

Common Stock

Purchase

Transaction value
$696,882
Shares
+212,464
Change %
+395%
Price
$3.28
Shares after
266,214
Date
02 Dec 2022
Ownership
By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ERNA transaction Derivative

Warrants (right to buy)

Purchase

Transaction value
$17,706
Shares
+141,644
Change %
Price
$0.1250*
Shares after
141,644
Date
02 Dec 2022
Ownership
By Purchase Capital LLC
Underlying class
Common Stock, par value $0.005 per share
Underlying amount
141,644
Exercise price
$3.28
Footnotes
F1
ERNA transaction Derivative

Warrants (right to buy)

Purchase

Transaction value
$53,116
Shares
+424,928
Change %
Price
$0.1250*
Shares after
424,928
Date
02 Dec 2022
Ownership
By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer
Underlying class
Common Stock, par value $0.005 per share
Underlying amount
424,928
Exercise price
$3.28
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .